Landscapes / Targets

kappa opioid receptor

7 drugs act on kappa opioid receptor, in 11 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs7

DrugHow it worksCompanyStageNext dateDetails
—
Approved in China 1 Apr 2027Phase 3 trial completes
Naldemedinenot checked
—
Approved in the EU 15 Jun 2028Phase 1/2 trial completes
Kappa opioid receptor agonist
Vifor Fresenius Medical Care Renal Pharma +1
Approved 15 Aug 2029Phase 2 trial completes
—
Phase 3 Aug 2027Phase 3 trial completes
—
AbbVie · Public ABBV
Phase 2 Sep 2027Phase 2 trial completes
—
Phase 2 31 Oct 2027Phase 2 trial completes
—
Phase 1 30 Dec 2027Phase 1 trial completes

About this list

Checked
6 of 7 drugs. The other 1 is marked “not checked” in the list. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Kappa opioid receptor

Following is part of Solo: you see every change to Kappa opioid receptor the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in